10Kabsch K,Alonso A.The human papillomavirus type 16 E5 protein impairs TRAIL -and FasL-mediated apoptosis in HaCaT cells by different mechanisms[J].J Virol,2002,76(23): 12162-12172.
1Chih H J, Lee AH, Colville L,et al. A review of dietary prevention of human papillomavirus-related infection of the cervix and cervical in- traepithelial neoplasia[ J]. Nutr Cancer,2013,65 (3) :317-328.
2Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008 [ J ]. Int J Cancer, 2010, 127 (12) :2893-2917.
3Ciarrocca K, Jackson LL, De Rossi SS. Human papillomavirus: the fundamentals of HPV for oral health care providers[J]. J Calif Dent Assoc, 2013, 41 (5) :349-355.
4Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999,189 ( 1 ) : 12-19.
5Smith JL. A review of hepatitis E virus[J]. J Food Prot, 2001, 64(4) :572-586.
6Wang SS, Schiffman M, Herrero R, et al. Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica[ J]. Br J Cancer, 2004, 91 (7) :1269-1274.
7Utba NM. The prevalence of hepatitis E virus in A1-Sadr City- Baghdad[ J]. Clin Lab, 2013, 59 (1-2) : 115-120.
8Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers [J]. Vaccine, 2006, 24 Suppl 3 :S3-S25.
9Zhang J, Li SW, Wu T, et al. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity [ J ]. Rev Med Virol, 2012, 22(5) :339-349.
10Watson-Jones D, Baisley K, Brown J, et al. High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects [ J ]. Sex Transm Infect, 2013, 89 ( 5 ) : 358-365.
